Ranbaxy is understood to have emerged as the sole Indian pharma entity to have moved into the next round of bidding for the generic business of Merck, even as compatriot Cipla claimed to be "very much in the race."
With nearly 5% share in the world generic market, are Indian pharma companies ready to go global? How competitive are their current business models?
Unhappy with Chinese machinery and raw materials they have been importing so far, Pakistani pharmaceutical companies are now longing to increase their business ties with India, and asked New Delhi to relax the "stringent visa norms".
The company, which made the biggest ever acquisition in the Indian pharma history last year by taking over controlling stakes in DocPharma in Belgium, has finalised the Latin American deal and an announcement would be made soon.
Wockhardt Hospitals will expand to 10 to 15 hospitals over the next few years
A US court has ruled against Ranbaxy in its case for non-infringement and invalidation of two patents of its competitor Pfizer
The Budget will obviously be crucial. But US President Donald Trump may have even more of an influence than Finance Minister Arun Jaitley when it comes to sentiment, argues Devangshu Datta.
Ranbaxy Laboratories on Thursday announced that Teva Pharmaceuticals, under a mutual agreement with the Indian pharma major, has commercially launched its Quinapril HCL tablets in the US.
With India's imports exceeding exports, weak rupee does more harm than good. Analysts, however, say that rupee depriciation is positive for export-oriented sectors such as IT services, pharmaceuticals, textiles and automobiles
Nicholas Piramal India, a dominant player in the domestic pharmaceutical industry, appears to be unfazed by the anticipated consequences of the product patent regime that comes into play from January 2005.
Dying To Survive, on its way to becoming China's biggest box office hit, may compel the Xi Jinping government to change its policy towards Indian pharmaceutical companies, says Tarun Vijay.
The case was earlier heard by a different vacation bench which had on June 10 asked Sharma to substantiate his 'unfounded allegations' that the Indian pharma major was allegedly manufacturing and selling adulterated medicines.
Currently, 100 per cent FDI is permitted in brownfield pharma firms through clearance from the Foreign Investment Promotion Board.
US markets have been very lucrative for the Indian pharma companies and many companies such as Ranbaxy and Dr Reddy's capitalised on this opportunity.
The government is optimistic that the Indian pharma industry with a strength of 25,000 companies will be a leading player in the sector in the years to come.
Take the Rediff Business Quiz and find out how much you know about the pharma industry.
PHD Chamber of Commerce and Industry on Thursday asked the government to revamp tax structure and extend tax holidays for the high-cost and risky research and development sector
The Paytm employee, who tested positive for the contagious disease with flu like symptoms on Wednesday, came in touch with 91 people in Gurgaon, an official said, citing his counterpart in the suburban town.
He said it is indicative of the Indian economy's strength as a rich knowledge base.
Nothing is going to dramatically open up on May 3. There will be too many ifs and buts and terms and conditions and guidelines in leading one's life in various zones, reveals Sheela Bhatt.
Industry body Assocham on Tuesday said the Indian pharma industry would grow at 11 per cent to touch Rs 60,000 crore (Rs 600 billion) in 2007-08 from Rs 39,000 crore (Rs 390 billion) in 2003-04, when drugs worth $65 billion would go off patent.
In keeping with its increased thrust on new markets, Indian pharma major Ranbaxy said on Friday that it has established a subsidiary in Russia with 120 people to begin
Modi will meet US President Barack Obama at the White House on September 29-30.
Daiichi won't remain a major shareholder in Sun Pharma.
In a major boost to Ranbaxy Laboratories' exports to developed countries, the United States has approved marketing of flecainide acetate tablets in the country.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances